LAURA GRIMM: Open Payments
NPI 1407107485 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 18 payments from 8 companies in 2025. Trend: 2023 $755 · 2024 $118 · 2025 $424
Food & beverage: $407Education: $17
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 5 | $162 |
| Ardelyx, Inc. | 5 | $94 |
| Vifor Pharma, Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $18 |
| OPKO Pharmaceuticals, LLC | 1 | $17 |
Products named: Vafseo, IBSRELA, Veltassa, FARXIGA, Kerendia, PREVYMIS, Empaveli, RAYALDEE.
Industry payments across OH — which companies pay providers there.
